Angiotensin converting enzyme (ACE) inhibitors – perindopril

Last updated on September 26, 2024

Special Authority requests can now be submitted online. It's simple and quick!

This drug is eligible for automatic approval when patient meets criteria and the request is submitted by eForms.

Generic name		perindopril
Strength		2 mg, 4 mg, 8 mg
Form		tablet

Criteria	Approval period
Treatment failure on optimal dose of, or intolerance to, ramipril OR Complex patient requiring medications for co-existing chronic condition(s)	Indefinite

Criteria

Approval period

Treatment failure on optimal dose of, or intolerance to, ramipril

Complex patient requiring medications for co-existing chronic condition(s)

Indefinite

Practitioner exemptions

The following practitioners are not required to submit a Special Authority request for coverage:

Paediatric cardiology
Paediatrics

Special notes

PharmaCare does not cover perindopril in combination with indapamide.
Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.

Special Authority requests

Log in to eForms
HLTH 5328 - Special Authority Request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Angiotensin converting enzyme (ACE) inhibitors – perindopril

Practitioner exemptions

Special notes

Special Authority requests